A Phase II, Multicenter, Randomized, Observer-Blind, Controlled Study to Evaluate Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women
Clinical Trial Grant
Administered By
Obstetrics and Gynecology, Maternal Fetal Medicine
Awarded By
Novartis Vaccines and Diagnostics, Inc
Start Date
November 1, 2013
End Date
October 31, 2015
Administered By
Obstetrics and Gynecology, Maternal Fetal Medicine
Awarded By
Novartis Vaccines and Diagnostics, Inc
Start Date
November 1, 2013
End Date
October 31, 2015